SCHEMBL7745960

SCHEMBL7745960

CN(C)c1cnn(Cc2nc3ccccc3n2CCCS(C)(=O)=O)c(=O)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.40
USP2 O75604 2/20 0.40
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
TSHR P16473 3/20 0.36
POLB P06746 2/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
GRM2 Q14416 1/20 0.35
GAA P10253 1/20 0.35
MITF O75030 1/20 0.35
PAX8 Q06710 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7745952 0.89 RAB9A (0.45) SMN1; SMN2USP2KMT2AMEN1L3MBTL1
SCHEMBL7745944 0.83 SMN1; SMN2 (0.36) SMN1; SMN2USP2KMT2AMEN1L3MBTL1
SCHEMBL7741635 0.81 NPC1 (0.43) SMN1; SMN2USP2KMT2AMEN1L3MBTL1
SCHEMBL7740722 0.76 MEN1 (0.54) SMN1; SMN2USP2KMT2AMEN1L3MBTL1
SCHEMBL7740409 0.74 MEN1 (0.42) SMN1; SMN2USP2KMT2AMEN1L3MBTL1
SCHEMBL7745194 0.72 SMN1; SMN2 (0.59) SMN1; SMN2KMT2AMEN1TSHRPOLB
SCHEMBL18543026 0.71 RAB9A (0.52) SMN1; SMN2KMT2AMEN1CYP1A2CYP2C19
SCHEMBL15416721 0.69 KMT2A (0.56) SMN1; SMN2USP2KMT2AMEN1L3MBTL1
SCHEMBL5858779 0.68 SLC9A1 (0.46) SMN1; SMN2USP2KMT2AMEN1L3MBTL1
SCHEMBL7745475 0.68 AKR1B1 (0.41) SMN1; SMN2USP2KMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed